Bryn Mawr Trust CO Bristol Myers Squibb CO Transaction History

Bryn Mawr Trust CO

$2.54 Billion
Q2 2024

A detailed history of Bryn Mawr Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bryn Mawr Trust CO holds 86,298 shares of BMY stock, worth $4.85 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

86,298

Previous 86,772 0.55%

Holding current value

$4.85 Million

Previous $4.71 Million 23.85%

% of portfolio

0.14%

Previous 0.19%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $19,078 - $25,117	-474 Reduced 0.55%	86,298 $3.58 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $384,031 - $435,417	-8,004 Reduced 8.45%	86,772 $4.71 Million
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $3,936 - $4,401	-68 Reduced 0.07%	94,776 $5.5 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $113,531 - $126,058	-1,782 Reduced 1.84%	94,844 $6.07 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $78,589 - $89,137	-1,196 Reduced 1.22%	96,626 $6.7 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $66,220 - $78,414	-967 Reduced 0.98%	97,822 $7.04 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $256 - $151,682	-1,974 Reduced 1.96%	98,789 $7.02 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $270,001 - $297,365	-3,718 Reduced 3.56%	100,763 $7.76 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $33,506 - $40,177	-545 Reduced 0.52%	104,481 $7.63 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $468,189 - $545,799	-8,730 Reduced 7.67%	105,026 $6.55 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $258,395 - $302,676	-4,367 Reduced 3.7%	113,756 $6.73 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $37,517 - $40,856	606 Added 0.52%	118,123 $7.89 Million
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $120,104 - $135,081	-2,024 Reduced 1.69%	117,517 $7.42 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $40,822 - $46,259	707 Added 0.59%	119,541 $7.42 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $47,609 - $52,757	-829 Reduced 0.69%	118,834 $7.17 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $307,704 - $359,737	-5,613 Reduced 4.48%	119,663 $7.04 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $63,196 - $91,839	-1,362 Reduced 1.08%	125,276 $6.98 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $117,070 - $152,708	2,379 Added 1.91%	126,638 $8.13 Million
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $144,220 - $170,994	-3,372 Reduced 2.64%	124,259 $6.3 Million
Q2 2019 Aug 15, 2019	SELL	$44.62 - $49.34 $177,052 - $195,781	-3,968 Reduced 3.02%	127,631 $5.79 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $139,059 - $165,811	-3,082 Reduced 2.29%	131,599 $6.28 Million
Q4 2018 Aug 28, 2019	BUY	$48.76 - $63.23 $146,280 - $189,690	3,000 Added 2.28%	134,681 $7 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $556,692 - $721,896	-11,417 Reduced 7.98%	131,681 $6.85 Million
Q3 2018 Aug 28, 2019	BUY	$55.19 - $62.25 $165,570 - $186,750	3,000 Added 2.14%	143,098 $8.88 Million
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $349,904 - $394,665	-6,340 Reduced 4.33%	140,098 $8.7 Million
Q2 2018 Aug 28, 2019	BUY	$50.53 - $62.98 $151,590 - $188,940	3,000 Added 2.09%	146,438 $8.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $39,110 - $48,746	-774 Reduced 0.54%	143,438 $7.94 Million
Q1 2018 Aug 28, 2019	BUY	$59.92 - $68.98 $179,760 - $206,940	3,000 Added 2.12%	144,212 $9.12 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $217,090 - $249,914	-3,623 Reduced 2.5%	141,212 $8.93 Million
Q4 2017 Aug 28, 2019	BUY	$59.94 - $65.35 $179,820 - $196,049	3,000 Added 2.12%	144,835 $8.88 Million
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $495,164 - $539,856	-8,261 Reduced 5.5%	141,835 $8.69 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $8.29 Million - $9.57 Million	150,096	150,096 $9.57 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Bristol Myers Squibb CO Transaction History